Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
29 hedge funds and large institutions have $92.3M invested in Acer Therapeutics Inc in 2018 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 0 reducing their positions, and 4 closing their positions.
493% more capital invested
Capital invested by funds: $15.6M → $92.3M (+$76.7M)
300% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 4
71% more funds holding
Funds holding: 17 → 29 (+12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$15.2M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$11.8M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$11.4M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$7.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.64M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$879K |
| 3 |
AIS
Accurate Investment Solutions
Seven Fields,
Pennsylvania
|
-$1K |
ACER Hedge Fund Activity: Q3 2018 in Review
29 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2018, worth a combined $92.3M — up 493% from $15.6M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ACER positions and 4 closed out — a net gain of 12 holders — while 9 added to existing stakes and 0 trimmed.
The largest buyer was Vivo Capital, opening a new position worth an estimated $15.2M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $1.64M sold.
- 29 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2018, up from 17 in Q2 2018.
- Funds reported $92.3M of Acer Therapeutics Inc stock for Q3 2018, up 493% quarter-over-quarter.
- 16 funds opened new Acer Therapeutics Inc positions in Q3 2018 and 4 closed out, a net change of +12 holders.
- The largest Acer Therapeutics Inc buyer in Q3 2018 was Vivo Capital, an estimated $15.2M added.
- The largest Acer Therapeutics Inc seller in Q3 2018 was Alyeska Investment Group, an estimated $1.64M sold.
Based on aggregated 13F filings for Q3 2018.